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Goniothalamin is a biologically active styrylpyrone derivative isolated from various 
Goniothalamus sp., belonging to the Annonacae family. This plant extract has been 
reported to be cytotoxic towards several tumor cell lines such as pancreas carcinoma 
(PANC-1), gastric carcinoma (HGC-27) and breast carcinoma (MCF-7). The purpose of 
this study was to examine and characterize the in vitro cytotoxicity effect of 
goniothalamin on the human hepatocellular carcinoma HepG2 cells and normal liver 
Chang cells and also to study the morphological and biochemical changes of 
goniothalamin-treated HepG2 and Chang cells. Goniothalamin (2.3 -150 μM; 24, 48 and 
72 hours) treatment to HepG2 and Chang cells resulted in a dose and time dependent 
inhibition of cell growth as assessed by MTT and LDH assays. The data suggest that 
goniothalamin selectively inhibits HepG2 cells (IC50 of MTT= 4.6(±0.23) µM; IC50 of 
LDH= 5.20(±0.01) µM for 72 hours) with less inhibition of growth in Chang cells (IC50 
of MTT= 35.0(±0.09) µM; IC50 of LDH= 32.5(± 0.04) µM for 72 hours. The cytotoxic 
activity of goniothalamin on HepG2 cells was confirmed by Trypan blue dye exclusion 
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assay. Goniothalamin reduced the number of viable cells (non-stained) associated with 
an increase on the number of non-viable cells (stained) and the Viability Indexes were 
52 ± 1.73% for HepG2 cells and 62 ± 4.36% for Chang cells at IC50 after 72 hours. Cells 
were exposed to goniothalamin at lowest concentration (2.3 µM), IC50 (of MTT results), 
and highest concentration (150 µM) for 24, 48, or 72 hours and then examined for 
effects on cell cycle (using the flow cytometry) or proliferation (using the BrdU ELISA 
assay). The cytotoxic activity of goniothalamin was related to the inhibition of DNA 
synthesis, as revealed by the reduction of BrdU incorporation. At 72 hours with the 
lowest goniothalamin concentration of 2.3 µM, the normal liver Chang cells retained 
97.6% of control proliferation while the liver cancer HepG2 cells were reduced to 19.8% 
of control proliferation. Goniothalamin caused the accumulation of hypodiploid 
apoptotic cells in cell cycle analysis by flow cytometry. Goniothalamin arrested HepG2 
and Chang cells in the G2/M phase with different degrees. Light microscopy 
examination of HepG2 and Chang cells exposed to different concentrations of 
goniothalamin up to 72 h demonstrated changes in cellular morphology; i.e. cell 
rounding followed by a loss of adherence with subsequent cell shrinkage and blebbing. 
In addition, the apoptotic cells were more abundant in goniothalamin-treated HepG2 
cells (84 ± 4.58%) for 72 hours than in untreated cell (4 ± 2.65%) upon measurement by 
TUNEL staining. In view of the toxicity of goniothalamin, the kind of cell death, namely 
apoptosis or necrosis, was assessed. Therefore, staining with fluorescence labeled 
annexin V in combination with propidium iodide was performed on HepG2 and Chang 
cells exposed to goniothalamin. The laser scanning cytometry of propidium iodide and 
annexin V-stained cells indicated that the growth inhibiting effect of goniothalamin was 
consistent with a strong induction of apoptosis at late stage. This is because the cellular 
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membrane integrity was lost, so the cells exhibited annexin V- and propidium iodide-
double positive up to 85.87 ± 0.78 and 57.69 ± 1.12 in HepG2 and Chang cells after 24 
hours, respectively. In order to confirm apoptotic mechanism in the goniothalamin-
treated cells, caspase 3 activity upon the same treatment conditions was carried out. The 
results indicate that caspase 3 activity was significantly elevated early in IC50 treated 
Chang cells (574% of control)  after 24 hours and late in IC50 treated cells after 72 hours 
in HepG2 cells (879% of control). Our findings suggest a potential mechanism for the 
strong growth inhibitory effect of goniothalamin on this HepG2 liver cancer cells. 
However, less sensitivity to normal liver Chang cell line was observed by this 
compound. An important feature of the cytotoxicity by goniothalamin is that it is 
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Goniothalamin adalah molekul aktif terbitan styrylpyrone secara biologi yang telah 
diasingpisahkan daripada spesies Goniothalamus dari Famili Annonacea. Ekstrak 
tumbuhan ini dilaporkan memberi kesan sitotoksik terhadap beberapa sel tumor asas 
seperti sel karsinoma pankreas (PANC-1), sel karsinoma gastrik (HGC-27) dan sel 
karsinoma payudara (MCF-7). Tujuan kajian ini adalah untuk memeriksa dan 
mencirikan kesan sitotoksiti goniothalamin pada sel karsinoma hepar manusia (HepG2) 
dan sel Chang secara in vitro dan juga mengkaji morfologi dan perubahan biokimia pada 
sel HepG2 dan sel Chang yang dirawat dengan goniothalamin. Rawatan goniothalamin 
(2.3-150 µM; 24, 48 dan 72 jam) pada sel HepG2 dan sel Chang dengan menggunakan 
pengujian MTT dan LDH, menghasilkan keputusan perencatan pertumbuhan sel yang 
berkadaran dengan dos dan masa. Data mencadangkan goniothalamin merencatkan sel 
HepG2 (IC50 MTT=4.6 (±0.23) µM; IC50 LDH=5.20(µM) untuk 72 jam) dengan sedikit 
perencatan pertumbuhan pada sel Chang (IC50 MTT=35.0 (±0.09) µM; IC50 LDH= 
32.5(±0.04) µM untuk 72 jam. Aktiviti sitotoksiti goniothalamin pada sel HepG2 telah 
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juga dipastikan menggunakan pengujian pewarna biru Trypan. Goniothalamin telah 
mengurangkan bilangan sel hidup (tidak berwarna) yang berhubung dengan 
pertambahan bilangan sel mati (berwarna) dan indek viabiliti pada pengukuran IC50 
adalah 52 ± 1.73% bagi sel HepG2 dan 62 ± 4.36 % untuk sel Chang selepas 72 jam. 
Sel-sel yang didedahkan pada goniothalamin pada kepekatan terendah (2.3 µM), IC50 
(keputusan MTT), dan kepekatan tertinggi (150 µM) pada 24, 48 atau 72 jam dan 
kemudian diperiksa kesan pada kitaran sel (menggunakan aliran sitometrik) atau 
pertumbuhan sel (menggunakan pengujian BrdU ELISA). Aktiviti sitotoksik 
goniothalamin adalah berkait dengan perencatan sintesis DNA, seperti yang ditunjukkan 
oleh pengurangan penggabungan BrdU. Pada  72 jam terakhir untuk goniothalamin 
berkepekatan 2.3 µM, peningkatan sel normal hati Chang kekal pada 97.6% berbanding 
pertumbuhan sel kawalan, sementara sel kanser hati HepG2 telah menurun kepada 
19.8% berbanding pertumbuhan sel kawalan. Goniothalamin menyebabkan 
pengumpulan sel apoptotik hipodiploid pada kitar sel yang dianalisis menggunakan 
aliran sitometri. Goniothalamin menghentikan sel HepG2 dan sel Chang pada fasa G2/M 
pada darjah yang berbeza. Pemeriksaan melalui mikroskop cahaya pada sel HepG2 dan 
sel Chang yang terdedah terhadap goniothalamin pada kepekatan yang berbeza hingga 
72 jam menunjukkan perubahan pada morfologi sel; i.e. sel membulat dan diikuti 
dengan kehilangan sifat pelekatan antara sel seterusnya menghasilkan sel yang kecut dan 
mengerut. Tambahan pula, sel apoptotik adalah lebih banyak dalam sel HepG2 yang 
dirawat dengan goniothalamin (84 ± 4.58%) untuk 72 jam berbanding sel-sel yang tidak 
dirawat (4 ± 2.65%) yang diukur dengan teknik warnaan TUNEL. Melalui kajian 
toksisiti goniothalamin, jenis kematian sel iaitu apoptosis atau nekrosis perlu dinilai. 
Oleh itu, pewarnaan dengan fluoresen yang dilabelkan dengan annexin V dengan 
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gabungan propidium iodida telah dilakukan pada sel HepG2 dan sel Chang yang 
terdedah pada goniotahlamin. Imbasan pancaran laser sitometri propidium iodida dan 
annexin V pada sel yang diwarnakan telah menunjukkan bahawa perencatan 
pertumbuhan akibat goniothalamin adalah konsisten dengan aruhan kuat proses 
apoptosis pada peringkat akhir disebabkan oleh kehilangan intergriti membran, maka 
sel-sel tersebut telah mempamerkan peningkatan bacaan dwi-positif untuk annexin V 
dan propidium iodida sehingga 85.87 ± 0.78 dan 57.69 ± 1.12 untuk sel HepG2 dan sel 
Chang masing-masing selepas 24 jam. Dalam menastikan mekanisma apoptotik bagi sel 
yang dirawat dengan goniothalamin, pengukuran aktiviti caspase 3 telah dijalankan 
dengan keadaan ujikaji yang sama. Keputusan ujikaji menunjukkan aktiviti caspase 3 
adalah meningkat awal dengan signifikan dalam sel Chang yang dirawat IC50 (574% 
berbanding kawalan) iaitu selepas 24 jam dan akhir pada sel HepG2 yang dirawat IC50 
iaitu selepas 72 jam (879 % berbanding kawalan). Hasil kajian ini mencadangkan suatu 
mekanisma yang mungkin untuk perencatan kuat pertumbuhan akibat goniothalamin 
pada sel cancer hati (HepG2) dengan sensitiviti yang rendah pada sel asas hati normal 
Chang terhadap bahan ini. Suatu ciri penting sitotoksisiti goniothalamin adalah 
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Goniothalamus macrophyllus (locally named "Gajah beranak") is used traditionally 
as health tonic during pregnancy and to treat cold as well as fever (Burkill, 1953). 
The screening of this plant for bioactive compounds has resulted in the isolation of a 
large number of cytotoxic compounds, notably styryl-lactone derivatives, 
acetogenins, aporphine alkaloids and related alkaloids (Blasquez et al., 1999). These 
compounds have also been found to possess strong antimicrobial (Khan et al., 1999), 
larvicidal (Ee, 1998), antimalarial (Likhitwitayawuid et al., 1997) and embryotoxic 
activities (Sam et al., 1987).  
 
Goniothalamin is a styryl-lactone compound isolated from the root and stem of 
Goniothalamus macrophyllus (Sam et al., 1987). Cytotoxicity of goniothalamin was 
reported in a number of carcinoma cell types isolated from a variety of tissues such 
as colon cancer cell line (Ângelo et al., 2005 ), breast cancer cell lines (Chen et al., 
2005)  and lung carcinoma (Chatchai et al., 2005). Skin fibroblast, human fibroblast 
and bovine kidney are normal cell lines that showed resistant to this compound 
(Chatchai et al., 2005). 
 
More than 80% of Hepatocellular carcinoma HCC cases occur in the Far East and 
Southeast Asia. Although immunization has been successful against hepatitis B virus 
(HBV), a changing disease burden of HCC has been observed in many parts of the 
 2
world because of the increasing prevalence and duration of hepatitis C virus (HCV) 
infection in these countries (Kao and Chen, 2005). 
 
Hepatocellular carcinoma (HCC) is refractory to chemotherapy because of tumor 
heterogeneity and the development of multidrug resistance phenotypes (Huang et al., 
1992; Legoix et al., 1999). The Hepatocellular Carcinoma HCC cells are presenting 
mutations of p53 (transcription factor works as a tumor suppressor that is involved in 
preventing cancer), which lead to more aggressive resistance to chemotherapy 
(Heinze et al., 1999)  
 
Doxorubicin is the best systemic chemotherapy with a variety of agents, including, 
epirubicin, mitoxantrone, cisplatin, and etoposide, either alone or in combination 
(Shah et al., 1998). It is often used in patients with HCC disseminated beyond the 
liver, although the response rates are generally of the order of only 15 %. In addition 
to that, doxorubicin is expensive and has serious side effects such as nausea, 
vomiting, mucositis, ulceration, necrosis of the colon and acute myeloid leukemia 
with a preleukemic phase and may cause heart failure (British Medical Association 
and Royal Pharmaceutical Society of Great Britain RPSGB, 2006). 
 
Plant bioactive compounds have fewer side effects with low-cost when used in 
chemotherapy. Thus, the gearing of compounds, extracted from plants, for medicinal 
purposes becomes a workable thing. Based on this, the objectives of the study are: 
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1. To assess toxicity and selectivity of goniothalamin against Hepatocellular 
Carcinoma HepG2 cell line in comparison with normal liver (Chang) cell 
line. 
2. To determine the mechanism of cytotoxicity, the treated cells with 
goniothalamin, have behaved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
